ID   PTPRU_HUMAN             Reviewed;        1446 AA.
AC   Q92729; A6H8L1; O00197; P78399; Q59HA4; Q5SYU4; Q5SYU5; Q92735;
AC   Q92850;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase U;
DE            Short=R-PTP-U;
DE            EC=3.1.3.48;
DE   AltName: Full=Pancreatic carcinoma phosphatase 2;
DE            Short=PCP-2;
DE   AltName: Full=Protein-tyrosine phosphatase J;
DE            Short=PTP-J;
DE            Short=hPTP-J;
DE   AltName: Full=Protein-tyrosine phosphatase pi;
DE            Short=PTP pi;
DE   AltName: Full=Protein-tyrosine phosphatase receptor omicron;
DE            Short=PTP-RO;
DE   AltName: Full=Receptor-type protein-tyrosine phosphatase psi;
DE            Short=R-PTP-psi;
DE   Flags: Precursor;
GN   Name=PTPRU; Synonyms=FMI, PCP2, PTPRO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary gland;
RX   PubMed=8870675; DOI=10.1042/bj3190249;
RA   Crossland S., Smith P.D., Crompton M.R.;
RT   "Molecular cloning and characterization of PTP pi, a novel receptor-
RT   like protein-tyrosine phosphatase.";
RL   Biochem. J. 319:249-254(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CATALYTIC ACTIVITY,
RP   GLYCOSYLATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Pancreas;
RX   PubMed=8700514;
RA   Wang H.-Y., Lian Z., Lerch M.M., Chen Z., Xie W., Ullrich A.;
RT   "Characterization of PCP-2, a novel receptor protein tyrosine
RT   phosphatase of the MAM domain family.";
RL   Oncogene 12:2555-2562(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9070223; DOI=10.1006/bbrc.1997.6004;
RA   Wang B., Kishihara K., Zhang D., Hara H., Nomoto K.;
RT   "Molecular cloning and characterization of a novel human receptor
RT   protein tyrosine phosphatase gene, hPTP-J: down-regulation of gene
RT   expression by PMA and calcium ionophore in Jurkat T lymphoma cells.";
RL   Biochem. Biophys. Res. Commun. 231:77-81(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=9434160; DOI=10.1016/S0378-1119(97)00420-4;
RA   Avraham S., London R., Tulloch G.A., Ellis M., Fu Y., Jiang S.,
RA   White R.A., Painter C., Steinberger A.A., Avraham H.;
RT   "Characterization and chromosomal localization of PTPRO, a novel
RT   receptor protein tyrosine phosphatase, expressed in hematopoietic stem
RT   cells.";
RL   Gene 204:5-16(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RA   Banville D., Masson S., L'Abbe D., Stocco R., Shen S.-H.;
RT   "Cloning and expression of R-PTP-psi, a novel receptor protein
RT   tyrosine phosphatase related to the homophilic binding R-PTP-kappa and
RT   -mu.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 194-1446 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   INDUCTION.
RX   PubMed=10395944; DOI=10.1016/S0167-4889(99)00064-6;
RA   Wang B., Kishihara K., Zhang D., Sakamoto T., Nomoto K.;
RT   "Transcriptional regulation of a receptor protein tyrosine phosphatase
RT   gene hPTP-J by PKC-mediated signaling pathways in Jurkat and Molt-4 T
RT   lymphoma cells.";
RL   Biochim. Biophys. Acta 1450:331-340(1999).
RN   [11]
RP   FUNCTION, INTERACTION WITH KIT, PHOSPHORYLATION, PROTEOLYTIC
RP   PROCESSING, AND INDUCTION BY PHORBOL ESTER.
RX   PubMed=10397721;
RA   Taniguchi Y., London R., Schinkmann K., Jiang S., Avraham H.;
RT   "The receptor protein tyrosine phosphatase, PTP-RO, is upregulated
RT   during megakaryocyte differentiation and is associated with the c-Kit
RT   receptor.";
RL   Blood 94:539-549(1999).
RN   [12]
RP   FUNCTION, INTERACTION WITH CTNNB1, INDUCTION, AND MUTAGENESIS OF
RP   CYS-1085 AND CYS-1380.
RX   PubMed=12501215; DOI=10.1021/bi026095u;
RA   Yan H.-X., He Y.-Q., Dong H., Zhang P., Zeng J.-Z., Cao H.-F.,
RA   Wu M.-C., Wang H.-Y.;
RT   "Physical and functional interaction between receptor-like protein
RT   tyrosine phosphatase PCP-2 and beta-catenin.";
RL   Biochemistry 41:15854-15860(2002).
RN   [13]
RP   FUNCTION, INTERACTION WITH CTNNB1, AND MUTAGENESIS OF CYS-1085 AND
RP   CYS-1380.
RX   PubMed=16574648; DOI=10.1074/jbc.M602607200;
RA   Yan H.-X., Yang W., Zhang R., Chen L., Tang L., Zhai B., Liu S.-Q.,
RA   Cao H.-F., Man X.-B., Wu H.-P., Wu M.-C., Wang H.-Y.;
RT   "Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling
RT   and increases E-cadherin-dependent cell adhesion.";
RL   J. Biol. Chem. 281:15423-15433(2006).
RN   [14]
RP   INTERACTION WITH AP3B1.
RX   PubMed=17622474; DOI=10.1111/j.1745-7270.2007.00303.x;
RA   Dong H., Yuan H., Jin W., Shen Y., Xu X., Wang H.-Y.;
RT   "Involvement of beta3A subunit of adaptor protein-3 in intracellular
RT   trafficking of receptor-like protein tyrosine phosphatase PCP-2.";
RL   Acta Biochim. Biophys. Sin. 39:540-546(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-848 AND SER-853, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-853, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-830; TRP-835 AND CYS-856.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Tyrosine-protein phosphatase which dephosphorylates
CC       CTNNB1. Regulates CTNNB1 function both in cell adhesion and
CC       signaling. May function in cell proliferation and migration and
CC       play a role in the maintenance of epithelial integrity. May play a
CC       role in megakaryocytopoiesis. {ECO:0000269|PubMed:10397721,
CC       ECO:0000269|PubMed:12501215, ECO:0000269|PubMed:16574648}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000269|PubMed:8700514}.
CC   -!- SUBUNIT: Forms homooligomeric complexes which mediate cell
CC       homotypic adhesion (Probable). Interacts (via the cytoplasmic
CC       juxtamembrane domain) with CTNNB1; may mediate interaction with
CC       the cadherin/catenin adhesion complex. Interacts with KIT. May
CC       interact with AP3B1. {ECO:0000269|PubMed:10397721,
CC       ECO:0000269|PubMed:12501215, ECO:0000269|PubMed:16574648,
CC       ECO:0000269|PubMed:17622474, ECO:0000305}.
CC   -!- INTERACTION:
CC       P10721:KIT; NbExp=2; IntAct=EBI-7052301, EBI-1379503;
CC   -!- SUBCELLULAR LOCATION: Cell junction {ECO:0000269|PubMed:8700514}.
CC       Cell membrane {ECO:0000269|PubMed:8700514}; Single-pass type I
CC       membrane protein {ECO:0000269|PubMed:8700514}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q92729-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92729-2; Sequence=VSP_037082;
CC       Name=3;
CC         IsoId=Q92729-3; Sequence=VSP_037082, VSP_037084;
CC       Name=4; Synonyms=PTPRO;
CC         IsoId=Q92729-4; Sequence=VSP_037082, VSP_037083, VSP_037085;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High levels in brain, pancreas, and skeletal
CC       muscle; less in colon, kidney, liver, stomach, and uterus; not
CC       expressed in placenta and spleen. Also detected in heart,
CC       prostate, lung, thymus, testis and ovary. Ubiquitously expressed
CC       in brain. Expressed by hematopoietic stem cells.
CC       {ECO:0000269|PubMed:8700514, ECO:0000269|PubMed:8870675,
CC       ECO:0000269|PubMed:9070223, ECO:0000269|PubMed:9434160}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain, lung and kidney.
CC       {ECO:0000269|PubMed:9434160}.
CC   -!- INDUCTION: Up-regulated upon cell contact (at protein level).
CC       Down-regulated by phorbol ester (at protein level) and calcium
CC       ionophore but up-regulated by phorbol ester in megakaryocytic
CC       cells (PubMed:10397721). {ECO:0000269|PubMed:10395944,
CC       ECO:0000269|PubMed:10397721, ECO:0000269|PubMed:12501215,
CC       ECO:0000269|PubMed:9070223}.
CC   -!- PTM: The extracellular domain is proteolytically processed through
CC       cleavage within the fibronectin type-III 4 domain (By similarity).
CC       In addition to the 190 kDa full-length protein, proteolytic
CC       products of 100 kDa, 80 kDa and 73 kDa are observed. {ECO:0000250,
CC       ECO:0000269|PubMed:10397721}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:8700514}.
CC   -!- PTM: Phosphorylated on tyrosine residues upon activation of KIT
CC       with stem cell factor (SCF). The 73 kDa proteolytic product is not
CC       phosphorylated. {ECO:0000269|PubMed:10397721}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2B subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA65016.1; Type=Miscellaneous discrepancy; Note=Several sequencing problems.; Evidence={ECO:0000305};
CC       Sequence=CAA65832.1; Type=Miscellaneous discrepancy; Note=Several sequencing problems.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X95712; CAA65016.1; ALT_SEQ; mRNA.
DR   EMBL; X97198; CAA65832.1; ALT_SEQ; mRNA.
DR   EMBL; U73727; AAB51343.1; -; mRNA.
DR   EMBL; U71075; AAC51938.1; -; mRNA.
DR   EMBL; U60289; AAB07074.1; -; Genomic_DNA.
DR   EMBL; AL645859; CAH72393.1; -; Genomic_DNA.
DR   EMBL; AL049570; CAH72393.1; JOINED; Genomic_DNA.
DR   EMBL; AL590729; CAH72393.1; JOINED; Genomic_DNA.
DR   EMBL; AL645859; CAH72394.1; -; Genomic_DNA.
DR   EMBL; AL049570; CAH72394.1; JOINED; Genomic_DNA.
DR   EMBL; AL590729; CAH72394.1; JOINED; Genomic_DNA.
DR   EMBL; AL590729; CAI14331.1; -; Genomic_DNA.
DR   EMBL; AL049570; CAI14331.1; JOINED; Genomic_DNA.
DR   EMBL; AL645859; CAI14331.1; JOINED; Genomic_DNA.
DR   EMBL; AL590729; CAI14332.1; -; Genomic_DNA.
DR   EMBL; AL049570; CAI14332.1; JOINED; Genomic_DNA.
DR   EMBL; AL645859; CAI14332.1; JOINED; Genomic_DNA.
DR   EMBL; AL049570; CAI20946.1; -; Genomic_DNA.
DR   EMBL; AL590729; CAI20946.1; JOINED; Genomic_DNA.
DR   EMBL; AL645859; CAI20946.1; JOINED; Genomic_DNA.
DR   EMBL; AL049570; CAI20947.1; -; Genomic_DNA.
DR   EMBL; AL590729; CAI20947.1; JOINED; Genomic_DNA.
DR   EMBL; AL645859; CAI20947.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX07651.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07652.1; -; Genomic_DNA.
DR   EMBL; BC146655; AAI46656.1; -; mRNA.
DR   EMBL; AB208855; BAD92092.1; -; mRNA.
DR   CCDS; CCDS334.1; -. [Q92729-1]
DR   CCDS; CCDS335.1; -. [Q92729-2]
DR   CCDS; CCDS44098.2; -. [Q92729-4]
DR   CCDS; CCDS53290.1; -. [Q92729-3]
DR   PIR; JC5290; JC5290.
DR   PIR; S72441; S72441.
DR   RefSeq; NP_001181930.1; NM_001195001.1. [Q92729-3]
DR   RefSeq; NP_005695.3; NM_005704.4. [Q92729-1]
DR   RefSeq; NP_573438.3; NM_133177.3. [Q92729-4]
DR   RefSeq; NP_573439.2; NM_133178.3. [Q92729-2]
DR   UniGene; Hs.19718; -.
DR   ProteinModelPortal; Q92729; -.
DR   SMR; Q92729; -.
DR   BioGrid; 115386; 14.
DR   IntAct; Q92729; 1.
DR   MINT; MINT-1349420; -.
DR   STRING; 9606.ENSP00000334941; -.
DR   ChEMBL; CHEMBL1961785; -.
DR   DEPOD; Q92729; -.
DR   iPTMnet; Q92729; -.
DR   PhosphoSitePlus; Q92729; -.
DR   BioMuta; PTPRU; -.
DR   DMDM; 229462800; -.
DR   MaxQB; Q92729; -.
DR   PaxDb; Q92729; -.
DR   PeptideAtlas; Q92729; -.
DR   PRIDE; Q92729; -.
DR   DNASU; 10076; -.
DR   Ensembl; ENST00000345512; ENSP00000334941; ENSG00000060656. [Q92729-1]
DR   Ensembl; ENST00000373779; ENSP00000362884; ENSG00000060656. [Q92729-2]
DR   Ensembl; ENST00000428026; ENSP00000392332; ENSG00000060656. [Q92729-3]
DR   Ensembl; ENST00000460170; ENSP00000432906; ENSG00000060656. [Q92729-4]
DR   GeneID; 10076; -.
DR   KEGG; hsa:10076; -.
DR   UCSC; uc001bru.4; human. [Q92729-1]
DR   CTD; 10076; -.
DR   DisGeNET; 10076; -.
DR   GeneCards; PTPRU; -.
DR   H-InvDB; HIX0000346; -.
DR   HGNC; HGNC:9683; PTPRU.
DR   HPA; CAB011476; -.
DR   HPA; HPA039832; -.
DR   MIM; 602454; gene.
DR   neXtProt; NX_Q92729; -.
DR   OpenTargets; ENSG00000060656; -.
DR   PharmGKB; PA34028; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOVERGEN; HBG062785; -.
DR   InParanoid; Q92729; -.
DR   KO; K16662; -.
DR   OMA; ASFQCMA; -.
DR   OrthoDB; EOG091G00CK; -.
DR   PhylomeDB; Q92729; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   ChiTaRS; PTPRU; human.
DR   GeneWiki; PTPRU; -.
DR   GenomeRNAi; 10076; -.
DR   PRO; PR:Q92729; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000060656; -.
DR   CleanEx; HS_PCP2; -.
DR   CleanEx; HS_PTPRU; -.
DR   Genevisible; Q92729; HS.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0034109; P:homotypic cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; NAS:UniProtKB.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell junction; Cell membrane;
KW   Complete proteome; Differentiation; Disulfide bond; Glycoprotein;
KW   Hydrolase; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Polymorphism; Protein phosphatase; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   1446       Receptor-type tyrosine-protein
FT                                phosphatase U.
FT                                /FTId=PRO_0000371658.
FT   TOPO_DOM     19    749       Extracellular. {ECO:0000255}.
FT   TRANSMEM    750    770       Helical. {ECO:0000255}.
FT   TOPO_DOM    771   1446       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       25    188       MAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00128}.
FT   DOMAIN      190    275       Ig-like C2-type.
FT   DOMAIN      288    383       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      386    484       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      485    591       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      592    674       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      888   1144       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1176   1439       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION      771    887       Mediates interaction with CTNNB1.
FT                                {ECO:0000250}.
FT   REGION     1085   1091       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1085   1085       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE   1380   1380       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1053   1053       Substrate. {ECO:0000255}.
FT   BINDING    1129   1129       Substrate. {ECO:0000250}.
FT   MOD_RES     848    848       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     853    853       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     863    863       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B1AUH1}.
FT   MOD_RES     865    865       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:B1AUH1}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    410    410       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    685    685       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    210    264       {ECO:0000255}.
FT   VAR_SEQ     774    783       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8700514,
FT                                ECO:0000303|PubMed:9070223,
FT                                ECO:0000303|PubMed:9434160,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_037082.
FT   VAR_SEQ     950    950       D -> DIRINRE (in isoform 4).
FT                                {ECO:0000303|PubMed:9434160}.
FT                                /FTId=VSP_037083.
FT   VAR_SEQ     993    995       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037084.
FT   VAR_SEQ    1329   1330       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9434160}.
FT                                /FTId=VSP_037085.
FT   VARIANT      60     60       T -> N (in dbSNP:rs35332573).
FT                                /FTId=VAR_055075.
FT   VARIANT     471    471       R -> L (in dbSNP:rs35745442).
FT                                /FTId=VAR_055076.
FT   VARIANT     830    830       H -> Y (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035650.
FT   VARIANT     835    835       R -> W (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs558954146).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035651.
FT   VARIANT     856    856       R -> C (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs763868325).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035652.
FT   VARIANT     940    940       N -> S (in dbSNP:rs2235937).
FT                                /FTId=VAR_055077.
FT   MUTAGEN    1085   1085       C->S: Loss of phosphatase activity toward
FT                                CTNNB1. Loss of the inhibitory effect on
FT                                CTNNB1 transcriptional activity without
FT                                effect on interaction with CTNNB1; when
FT                                associated with S-1380.
FT                                {ECO:0000269|PubMed:12501215,
FT                                ECO:0000269|PubMed:16574648}.
FT   MUTAGEN    1380   1380       C->S: No effect on phosphatase activity
FT                                toward CTNNB1. Loss of the inhibitory
FT                                effect on CTNNB1 transcriptional activity
FT                                without effect on interaction with
FT                                CTNNB1; when associated with S-1085.
FT                                {ECO:0000269|PubMed:12501215,
FT                                ECO:0000269|PubMed:16574648}.
FT   CONFLICT    359    360       LT -> S (in Ref. 4; AAC51938).
FT                                {ECO:0000305}.
FT   CONFLICT    401    401       T -> A (in Ref. 4; AAC51938).
FT                                {ECO:0000305}.
FT   CONFLICT    715    715       E -> D (in Ref. 3; AAB51343).
FT                                {ECO:0000305}.
FT   CONFLICT    840    841       SG -> GW (in Ref. 4; AAC51938).
FT                                {ECO:0000305}.
FT   CONFLICT   1215   1215       P -> A (in Ref. 5; AAB07074).
FT                                {ECO:0000305}.
FT   CONFLICT   1245   1245       A -> R (in Ref. 4; AAC51938).
FT                                {ECO:0000305}.
FT   CONFLICT   1399   1399       M -> I (in Ref. 4; AAC51938).
FT                                {ECO:0000305}.
FT   CONFLICT   1436   1436       A -> V (in Ref. 5; AAB07074).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1446 AA;  162423 MW;  76F9BD6EFABE8663 CRC64;
     MARAQALVLA LTFQLCAPET ETPAAGCTFE EASDPAVPCE YSQAQYDDFQ WEQVRIHPGT
     RAPADLPHGS YLMVNTSQHA PGQRAHVIFQ SLSENDTHCV QFSYFLYSRD GHSPGTLGVY
     VRVNGGPLGS AVWNMTGSHG RQWHQAELAV STFWPNEYQV LFEALISPDR RGYMGLDDIL
     LLSYPCAKAP HFSRLGDVEV NAGQNASFQC MAAGRAAEAE RFLLQRQSGA LVPAAGVRHI
     SHRRFLATFP LAAVSRAEQD LYRCVSQAPR GAGVSNFAEL IVKEPPTPIA PPQLLRAGPT
     YLIIQLNTNS IIGDGPIVRK EIEYRMARGP WAEVHAVSLQ TYKLWHLDPD TEYEISVLLT
     RPGDGGTGRP GPPLISRTKC AEPMRAPKGL AFAEIQARQL TLQWEPLGYN VTRCHTYTVS
     LCYHYTLGSS HNQTIRECVK TEQGVSRYTI KNLLPYRNVH VRLVLTNPEG RKEGKEVTFQ
     TDEDVPSGIA AESLTFTPLE DMIFLKWEEP QEPNGLITQY EISYQSIESS DPAVNVPGPR
     RTISKLRNET YHVFSNLHPG TTYLFSVRAR TGKGFGQAAL TEITTNISAP SFDYADMPSP
     LGESENTITV LLRPAQGRGA PISVYQVIVE EERARRLRRE PGGQDCFPVP LTFEAALARG
     LVHYFGAELA ASSLPEAMPF TVGDNQTYRG FWNPPLEPRK AYLIYFQAAS HLKGETRLNC
     IRIARKAACK ESKRPLEVSQ RSEEMGLILG ICAGGLAVLI LLLGAIIVII RKGRDHYAYS
     YYPKPVNMTK ATVNYRQEKT HMMSAVDRSF TDQSTLQEDE RLGLSFMDTH GYSTRGDQRS
     GGVTEASSLL GGSPRRPCGR KGSPYHTGQL HPAVRVADLL QHINQMKTAE GYGFKQEYES
     FFEGWDATKK KDKVKGSRQE PMPAYDRHRV KLHPMLGDPN ADYINANYID GYHRSNHFIA
     TQGPKPEMVY DFWRMVWQEH CSSIVMITKL VEVGRVKCSR YWPEDSDTYG DIKIMLVKTE
     TLAEYVVRTF ALERRGYSAR HEVRQFHFTA WPEHGVPYHA TGLLAFIRRV KASTPPDAGP
     IVIHCSAGTG RTGCYIVLDV MLDMAECEGV VDIYNCVKTL CSRRVNMIQT EEQYIFIHDA
     ILEACLCGET TIPVSEFKAT YKEMIRIDPQ SNSSQLREEF QTLNSVTPPL DVEECSIALL
     PRNRDKNRSM DVLPPDRCLP FLISTDGDSN NYINAALTDS YTRSAAFIVT LHPLQSTTPD
     FWRLVYDYGC TSIVMLNQLN QSNSAWPCLQ YWPEPGRQQY GLMEVEFMSG TADEDLVARV
     FRVQNISRLQ EGHLLVRHFQ FLRWSAYRDT PDSKKAFLHL LAEVDKWQAE SGDGRTIVHC
     LNGGGRSGTF CACATVLEMI RCHNLVDVFF AAKTLRNYKP NMVETMDQYH FCYDVALEYL
     EGLESR
//
